Maximum NBUVB Dose for Vitiligo Treatment
The highest safe dose of narrow-band UVB for vitiligo treatment varies by skin type, but peak doses reported without phototoxicity range from 532-734 mJ/cm², with the British Association of Dermatologists guideline recommending an arbitrary safety limit of 200 total treatments for skin types I-III, with higher limits permissible for darker skin types IV-VI at clinician discretion 1.
Dosing Framework by Skin Type
The evidence reveals important distinctions in maximum safe dosing:
Starting Doses
- Adults: Most commonly 200-280 mJ/cm² 1, 2
- Asian patients: Higher starting doses of 300-700 mJ/cm² may be appropriate based on MED testing, as the standard 280 mJ/cm² appears suboptimal 3
- Children: 150 mJ/cm² 2
Peak Doses Achieved
Research demonstrates that patients can safely reach substantially higher doses:
- Peak doses without phototoxicity: 532-734 mJ/cm² documented in clinical practice 4
- Mean cumulative dose: 155.3 J/cm² over treatment course 5
Treatment Limits and Safety Considerations
The British guideline establishes critical safety boundaries 1:
- Skin types I-III: Maximum 200 total treatments (more stringent than psoriasis protocols)
- Skin types IV-VI: Higher treatment numbers acceptable with informed consent
- Rationale: Vitiliginous skin lacks melanin protection, making it more susceptible to sunburn and photodamage than psoriatic skin
Dose Escalation Protocol
- Standard increment: 10-20% per treatment for first 20 sessions 6
- After initial phase: 2-5% increments until 50% repigmentation or persistent erythema develops 6
- Frequency: 2-3 times weekly 2, 5
Clinical Pitfalls and Caveats
Critical considerations for maximizing safety:
Previous PUVA exposure: Patients previously treated with PUVA show significantly lower response rates (36% vs 67%) and may require different dosing strategies 6
Site-specific response: Hands and feet consistently show poor response (<25% repigmentation) regardless of dose, so aggressive dosing for acral lesions is not justified 2, 6
Phototoxicity monitoring: Even at appropriate doses, mild erythema occurs in 80% and burning in 60% of patients 7. Grade 3-4 erythema can occur, necessitating dose adjustments 8
MED testing controversy: While only 30% of dermatologists perform MED testing 7, Asian populations show wide MED variability (300-700 mJ/cm² for lesional skin) suggesting potential benefit for personalized dosing 3
Treatment Duration Expectations
Realistic timelines for response:
- Early improvement: After 10-20 sessions 7
- >50% repigmentation: Typically requires 50-70 sessions in 85% of responders 7
- Optimal response: Average 74±24 exposures for >75% repigmentation 2
Maintenance Dosing
Once repigmentation achieved, maintenance therapy every 1-2 weeks is standard practice in 75% of cases 7, though the guideline notes that 12% of patients may experience relapse even with maintenance 1.
The evidence strongly supports that while individual treatment doses can safely reach 700+ mJ/cm², the cumulative treatment number (200 treatments for lighter skin types) represents the more critical safety threshold than any single dose maximum 1.